535 related articles for article (PubMed ID: 17054399)
21. Clinical genetics of Kallmann syndrome.
Dodé C; Hardelin JP
Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
[TBL] [Abstract][Full Text] [Related]
22. Kallmann syndrome in women: from genes to diagnosis and treatment.
Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
[TBL] [Abstract][Full Text] [Related]
23. Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome.
Jap TS; Chiu CY; Lirng JF; Won GS
J Endocrinol Invest; 2011 Jan; 34(1):53-9. PubMed ID: 20530987
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders.
Martinez-Mayer J; Perez-Millan MI
Front Endocrinol (Lausanne); 2023; 14():1132787. PubMed ID: 36843573
[TBL] [Abstract][Full Text] [Related]
25. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
Brioude F; Bouvattier CE; Lombès M
Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
[TBL] [Abstract][Full Text] [Related]
26. The PROK2/PROKR2 signaling pathway is required for the migration of most olfactory bulb interneurons.
Wen Y; Zhang Z; Li Z; Liu G; Tao G; Song X; Xu Z; Shang Z; Guo T; Su Z; Chen H; You Y; Li J; Yang Z
J Comp Neurol; 2019 Dec; 527(18):2931-2947. PubMed ID: 31132148
[TBL] [Abstract][Full Text] [Related]
27. PROKR2 mutations in autosomal recessive Kallmann syndrome.
Tommiska J; Toppari J; Vaaralahti K; Känsäkoski J; Laitinen EM; Noisa P; Kinnala A; Niinikoski H; Raivio T
Fertil Steril; 2013 Mar; 99(3):815-8. PubMed ID: 23200691
[TBL] [Abstract][Full Text] [Related]
28. Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.
Sinisi AA; Asci R; Bellastella G; Maione L; Esposito D; Elefante A; De Bellis A; Bellastella A; Iolascon A
Hum Reprod; 2008 Oct; 23(10):2380-4. PubMed ID: 18596028
[TBL] [Abstract][Full Text] [Related]
29. PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption.
Reynaud R; Jayakody SA; Monnier C; Saveanu A; Bouligand J; Guedj AM; Simonin G; Lecomte P; Barlier A; Rondard P; Martinez-Barbera JP; Guiochon-Mantel A; Brue T
J Clin Endocrinol Metab; 2012 Jun; 97(6):E1068-73. PubMed ID: 22466334
[TBL] [Abstract][Full Text] [Related]
30. PROK2/PROKR2 Signaling and Kallmann Syndrome.
Dodé C; Rondard P
Front Endocrinol (Lausanne); 2013; 4():19. PubMed ID: 23596439
[TBL] [Abstract][Full Text] [Related]
31. Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
Bry-Gauillard H; Trabado S; Bouligand J; Sarfati J; Francou B; Salenave S; Chanson P; Brailly-Tabard S; Guiochon-Mantel A; Young J
Ann Endocrinol (Paris); 2010 May; 71(3):158-62. PubMed ID: 20363464
[TBL] [Abstract][Full Text] [Related]
32. Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations.
Sbai O; Monnier C; Dodé C; Pin JP; Hardelin JP; Rondard P
FASEB J; 2014 Aug; 28(8):3734-44. PubMed ID: 24830383
[TBL] [Abstract][Full Text] [Related]
33. Pleiotropic effects of prokineticin 2 in the control of energy metabolism.
Magnan C; Migrenne-Li S
Biochimie; 2021 Jul; 186():73-81. PubMed ID: 33932486
[TBL] [Abstract][Full Text] [Related]
34. Prokineticins in central and peripheral control of human reproduction.
Traboulsi W; Brouillet S; Sergent F; Boufettal H; Samouh N; Aboussaouira T; Hoffmann P; Feige JJ; Benharouga M; Alfaidy N
Horm Mol Biol Clin Investig; 2015 Nov; 24(2):73-81. PubMed ID: 26574895
[TBL] [Abstract][Full Text] [Related]
35. The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions.
Semple RK; Topaloglu AK
Clin Endocrinol (Oxf); 2010 Apr; 72(4):427-35. PubMed ID: 19719764
[TBL] [Abstract][Full Text] [Related]
36. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism.
Bianco SD; Kaiser UB
Nat Rev Endocrinol; 2009 Oct; 5(10):569-76. PubMed ID: 19707180
[TBL] [Abstract][Full Text] [Related]
37. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
[TBL] [Abstract][Full Text] [Related]
38. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
Kim SH; Hu Y; Cadman S; Bouloux P
J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
[TBL] [Abstract][Full Text] [Related]
39. The novel function of miR-3195 for mutant PROK2 (c.223-4C>A) degradation.
Zhou S; Li P
Cell Biol Int; 2021 Feb; 45(2):404-410. PubMed ID: 33140874
[TBL] [Abstract][Full Text] [Related]
40. Sexually dimorphic distribution of Prokr2 neurons revealed by the Prokr2-Cre mouse model.
Mohsen Z; Sim H; Garcia-Galiano D; Han X; Bellefontaine N; Saunders TL; Elias CF
Brain Struct Funct; 2017 Dec; 222(9):4111-4129. PubMed ID: 28616754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]